IDA only vs United Kingdom: Access to anti-retroviral drugs, male
IDA only
80.4%
in 2024
United Kingdom
93.0%
in 2023
IDA only rank
4th
United Kingdom rank
7th
Access to anti-retroviral drugs, male over time
- IDA only
- United Kingdom
How they compare
United Kingdom currently reports 93.0% against 80.4% in IDA only, a difference of 12.6%.
That makes United Kingdom's figure about 1.2 times IDA only's.
Across all 8 years both countries report, United Kingdom has been ahead every year.
IDA only ranks 4th and United Kingdom ranks 7th of 19 groups.
United Kingdom has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | IDA only | United Kingdom | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 53.3% | 92.0% | 38.7% | United Kingdom |
| 2020s | 71.1% | 93.2% | 22.2% | United Kingdom |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, IDA only or United Kingdom?
- United Kingdom, at 93.0% against 80.4% in IDA only as of 2023.
- What is the difference in access to anti-retroviral drugs, male between IDA only and United Kingdom?
- 12.6%, with United Kingdom ahead.
- How many years of comparable data are there for IDA only and United Kingdom?
- 8 years are reported by both, from 2016 to 2023.
- How do IDA only and United Kingdom rank globally for access to anti-retroviral drugs, male?
- IDA only ranks 4th and United Kingdom ranks 7th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.